There is no cure for any of the major diseases caused by asbestos exposure. Asbestosis, the scarring disease, is irreversible. Mesothelioma, the cancer most closely linked to asbestos, remains fatal in the vast majority of cases, with only about 7% of patients in England surviving five years or more. That said, treatments have improved meaningfully in recent years, and some patients now live years longer than they would have a decade ago.
Asbestos itself isn’t a disease. It’s a mineral fiber that, once inhaled, can cause several distinct conditions: asbestosis (lung scarring), mesothelioma (cancer of the lining around the lungs or abdomen), and asbestos-related lung cancer. Each has its own outlook and treatment path, but none can be fully reversed or eliminated once established.
Why Asbestosis Can’t Be Reversed
Asbestosis develops when inhaled asbestos fibers become permanently lodged in the tiny air sacs of the lungs, triggering chronic inflammation that gradually replaces healthy tissue with scar tissue. According to the Mayo Clinic, there is no treatment that can reverse this damage. The scarring is permanent because the body cannot break down asbestos fibers or regenerate the air sacs they’ve destroyed.
Treatment for asbestosis focuses entirely on managing symptoms and slowing progression. For mild cases, that may mean monitoring lung function over time and avoiding further exposure. As the disease advances, supplemental oxygen can help with breathing difficulty, and pulmonary rehabilitation programs teach techniques to make the most of remaining lung capacity. In severe cases, a lung transplant is the only option that can restore normal breathing, but relatively few patients qualify.
Mesothelioma Treatment Has Improved, but Survival Remains Low
Mesothelioma is the most serious consequence of asbestos exposure, and it’s the disease most people are really asking about when they search for a cure. The cancer develops in the thin tissue lining the lungs (pleural mesothelioma) or abdomen and typically doesn’t appear until 20 to 50 years after exposure. By the time symptoms show up, the disease is often advanced.
The standard approach now combines multiple treatments. A large study comparing different treatment combinations found that patients who received chemotherapy alone had a median survival of 11.7 months. Adding immunotherapy pushed that to 18.2 months. Surgery combined with chemotherapy reached 20.7 months. And the most aggressive combination of surgery, immunotherapy, and chemotherapy achieved a median survival of 22.6 months. The difference between the least and most intensive approaches is nearly a year of additional life.
Patients who are candidates for surgery generally do better. Across all surgical patients in that study, median survival was 21.7 months compared to 13.6 months for those treated without surgery.
Newer Immunotherapy Options
The FDA approved a new first-line treatment combination for advanced mesothelioma in September 2024: an immunotherapy drug combined with standard chemotherapy. In the clinical trial that led to approval, patients receiving the combination lived a median of 17.3 months compared to 16.1 months with chemotherapy alone. While that difference in median survival looks modest, the immunotherapy group saw tumors shrink in 52% of patients versus 29% in the chemotherapy-only group.
For patients whose mesothelioma has continued growing after initial chemotherapy, a separate immunotherapy approach was tested in a UK trial of 332 people. Those receiving the treatment lived an average of 9.2 months compared to 6.6 months on placebo, and their risk of the cancer progressing dropped by 39%. These aren’t cures, but they represent real extensions of life that weren’t available even five years ago.
Surgery: What It Can and Can’t Do
Surgery for mesothelioma doesn’t aim to cure the disease in most cases. Instead, it removes as much visible tumor as possible to give chemotherapy and immunotherapy a better chance of controlling what remains. Two main surgical approaches exist. One removes the diseased lining around the lung while preserving the lung itself. The other removes the entire lung along with the surrounding lining.
Research comparing the two in patients with advanced disease found a striking difference. Patients who kept their lung had a median survival of 58.2 months, nearly five years. Those who had the lung removed survived a median of 13.5 months. The lung-preserving approach is now generally preferred when it’s feasible, though only a small fraction of mesothelioma patients are candidates for either surgery. The best outcomes come in carefully selected patients whose disease hasn’t spread widely.
Early Detection Remains Difficult
One reason asbestos-related cancers are so hard to treat is that they’re hard to catch early. Blood tests that measure certain proteins released by mesothelioma cells have been under development for years, but they aren’t reliable enough for routine screening. One protein marker has a false positive rate of about 5%, which sounds acceptable until you consider screening thousands of people, most of whom won’t have the disease. Another marker has a false positive rate closer to 15%.
These tests may have a role in monitoring people with known heavy asbestos exposure, but experts have concluded they aren’t practical for screening general communities or populations with lower exposure levels. For now, imaging scans remain the primary way mesothelioma is detected, and symptoms like persistent chest pain, shortness of breath, or unexplained fluid around the lungs are what typically prompt those scans.
What This Means if You’ve Been Exposed
If you’ve had significant asbestos exposure, the most important thing to understand is that not everyone who’s been exposed develops disease. But if disease does develop, catching it as early as possible gives you the most treatment options. Regular checkups with imaging are particularly important if you worked in construction, shipbuilding, mining, or other industries where asbestos was common before the 1980s.
For people already diagnosed with asbestosis, avoiding any further exposure to asbestos, cigarette smoke, and other lung irritants is critical. Smoking in particular compounds the damage and dramatically increases the risk of developing lung cancer on top of the scarring disease. Staying physically active within your limits and participating in pulmonary rehabilitation can help maintain the lung function you still have.
For mesothelioma patients, treatment decisions depend heavily on the stage at diagnosis, the location of the tumor, and overall health. The combination of surgery, chemotherapy, and immunotherapy offers the longest survival for those who qualify, but each case is different. The landscape of available treatments is broader now than at any point in the past, even if a true cure remains out of reach.